Patient-friendly summary
If you read nothing else
Bottom line
Across 22 international guidelines, exercise, staying active, and NSAIDs are the most consistently recommended treatments for low back pain, but guidelines differ markedly on many other interventions and often overlap or describe them ambiguously.
Moderate evidencePublished
Evidence hierarchy
Study participants
Guidelines for managing non-specific low back pain in adults (18+) from 15 countries/regions, published 2017-2022
Study Summary
This systematic review identified and compared 22 contemporary clinical practice guidelines (CPGs) for managing non-specific low back pain (LBP), published or updated between 2017 and 2022 across 15 countries and regions. Guideline quality was appraised with the AGREE II instrument; all were rated middle-to-high quality (mean scaled scores 42-86%), with none judged low quality. Across acute, subacute, and chronic LBP, the guidelines most consistently recommended active treatments such as therapeutic exercise, staying active, NSAIDs, and spinal manipulation, with acupuncture additionally featuring for chronic LBP. The authors report marked heterogeneity between guidelines, ambiguity in some recommendations, and frequent overlap between interventions (e.g., self-management vs. staying active, spinal manipulation vs. mobilisation).
Key Findings
| Finding | Detail | Impact |
|---|---|---|
| Therapeutic exercise is a core recommendation across all stages of LBP | Therapeutic exercise was recommended for acute LBP (9 of 13 relevant CPGs), subacute LBP (7 of 11), and chronic LBP (13 of 14), and was identified by the authors as one of the most consistently endorsed treatments across guidelines. | High |
| Guidelines consistently favour active over passive treatments | Key recommendations centred on active strategies including education, exercise, staying active, avoiding bed rest, and self-management, with less emphasis on pharmacological and surgical options. This aligns with The Lancet back pain series and prior CPG reviews. | High |
| Most consistently recommended treatments per stage | Acute LBP: NSAIDs, therapeutic exercise, staying active, spinal manipulation. Subacute LBP: NSAIDs, staying active, therapeutic exercise, spinal manipulation. Chronic LBP: therapeutic exercise, NSAIDs, acupuncture, spinal manipulation. Unspecified duration: staying active and self-management (each in all 5 relevant CPGs). | High |
| Marked heterogeneity and divergence between guidelines | Recommendations diverged notably for acupuncture, electrotherapy, heat and cold therapy, laser therapy, and most medications other than NSAIDs (paracetamol, opioids, muscle relaxants, antidepressants), reflecting differing prioritisation of efficacy vs. effectiveness evidence and varying medical practices across countries. | High |
| Inconsistent definitions of acute and subacute LBP | Chronic LBP was uniformly defined as >12 weeks, but the acute/subacute boundary varied: 6 guidelines defined acute as <4 weeks, 8 as <6 weeks, and 8 grouped acute and subacute as <12 weeks without a clear cutoff. | Medium |
| Overlap and ambiguity in how interventions are labelled | Guidelines often used different terms for the same interventions; self-management overlapped with staying active and unsupervised exercise, fear-avoidance education was confused with CBT, and spinal manipulation and spinal mobilisation were frequently used interchangeably without clear distinction. | Medium |
| Biopsychosocial multidisciplinary care is recommended but not well embedded | Few guidelines recommended a holistic interdisciplinary approach combining physical, psychological, social, and/or occupational interventions; most interventions were recommended as single treatments rather than as part of an integrated biopsychosocial program. | Medium |
| Guideline methodological quality was variable, with weaker domains identified | Seven of 22 CPGs were rated high quality (>=75% average or global rating >=6); the lowest-scoring AGREE II domains were stakeholder engagement, rigour of development, and applicability. Reporting of evidence search strategies was often poor, with literature-search-to-publication gaps of 10-32 months. | Medium |
Therapeutic exercise was recommended for acute LBP (9 of 13 relevant CPGs), subacute LBP (7 of 11), and chronic LBP (13 of 14), and was identified by the authors as one of the most consistently endorsed treatments across guidelines.
Key recommendations centred on active strategies including education, exercise, staying active, avoiding bed rest, and self-management, with less emphasis on pharmacological and surgical options. This aligns with The Lancet back pain series and prior CPG reviews.
Acute LBP: NSAIDs, therapeutic exercise, staying active, spinal manipulation. Subacute LBP: NSAIDs, staying active, therapeutic exercise, spinal manipulation. Chronic LBP: therapeutic exercise, NSAIDs, acupuncture, spinal manipulation. Unspecified duration: staying active and self-management (each in all 5 relevant CPGs).
Recommendations diverged notably for acupuncture, electrotherapy, heat and cold therapy, laser therapy, and most medications other than NSAIDs (paracetamol, opioids, muscle relaxants, antidepressants), reflecting differing prioritisation of efficacy vs. effectiveness evidence and varying medical practices across countries.
Chronic LBP was uniformly defined as >12 weeks, but the acute/subacute boundary varied: 6 guidelines defined acute as <4 weeks, 8 as <6 weeks, and 8 grouped acute and subacute as <12 weeks without a clear cutoff.
Guidelines often used different terms for the same interventions; self-management overlapped with staying active and unsupervised exercise, fear-avoidance education was confused with CBT, and spinal manipulation and spinal mobilisation were frequently used interchangeably without clear distinction.
Few guidelines recommended a holistic interdisciplinary approach combining physical, psychological, social, and/or occupational interventions; most interventions were recommended as single treatments rather than as part of an integrated biopsychosocial program.
Seven of 22 CPGs were rated high quality (>=75% average or global rating >=6); the lowest-scoring AGREE II domains were stakeholder engagement, rigour of development, and applicability. Reporting of evidence search strategies was often poor, with literature-search-to-publication gaps of 10-32 months.
Strengths
- Comprehensive structured and unstructured search across multiple medical and guideline-organisation databases, with no language or country restrictions
- Used the validated AGREE II instrument to appraise guideline methodological quality
- Recommendations clearly stratified by LBP duration (acute, subacute, chronic, unspecified) with a transparent classification scheme for synthesising recommendation wording
- Documented guideline characteristics including expert panel composition, evidence base, and patient involvement
- Findings consistent with The Lancet back pain series and prior guideline reviews, supporting external validity
Limitations
- Quality appraisal was performed by a single independent reviewer (with two others resolving discrepancies), whereas AGREE II recommends at least two appraisers, which may affect reliability
- Included guidelines were predominantly from North America and Europe, limiting global representation
- Restricting inclusion to guidelines from the past 6 years may have excluded broader global perspectives
- Does not fully capture disparities driven by resource availability, population needs, and cultural or healthcare-system differences
- No validated AGREE II threshold exists to distinguish high, medium, and low-quality guidelines, so quality cutoffs were set by author consensus
- As a guideline comparison, it summarises recommendations rather than directly measuring patient outcomes
Key Takeaways for Patients
What This Means for You
- 01For most low back pain, leading guidelines around the world agree on staying active and using exercise rather than resting in bed.
- 02Therapeutic exercise is recommended at every stage of low back pain - whether your pain is recent (acute), in between (subacute), or long-lasting (chronic).
- 03When medication is suggested, NSAIDs (anti-inflammatory pain relievers) are usually the first or second choice; guidelines are more cautious and less consistent about opioids, paracetamol, muscle relaxants, and antidepressants.
- 04Hands-on treatments like spinal manipulation and massage, and for chronic pain acupuncture and cognitive behavioural therapy, are recommended by many but not all guidelines, so approaches can differ between clinicians and countries.
- 05Guidelines do not all agree on every treatment, so it is reasonable to discuss the options and the reasoning behind them with your healthcare professional.
Read the Full Paper
Access the complete peer-reviewed study from BMC Musculoskeletal Disorders
View Full Study